Catalyst Pharmaceuticals (CPRX) Shares Outstanding (Diluted Average) (2018 - 2024)

Catalyst Pharmaceuticals (CPRX) has 7 years of Shares Outstanding (Diluted Average) data on file, last reported at $123.4 million in Q1 2024.

• For the quarter ending Q1 2024, Shares Outstanding (Diluted Average) rose 8.26% year-over-year to $123.4 million; the trailing twelve-month figure through Mar 2024 stood at $123.4 million (up 8.26% YoY), and the FY2023 full-year result was $113.8 million, up 2.13% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2024 stood at $123.4 million, up from $113.8 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $123.4 million in Q1 2024 and bottomed at $106.2 million in Q4 2020.
• The 5-year median for Shares Outstanding (Diluted Average) is $107.8 million (2021), against an average of $109.9 million.
• The widest annual swing landed in 2023, when Shares Outstanding (Diluted Average) dropped 4.84%; it then rose 8.26% in 2024.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $106.2 million in 2020, then climbed by 1.46% to $107.8 million in 2021, then climbed by 3.32% to $111.4 million in 2022, then advanced by 2.13% to $113.8 million in 2023, then climbed by 8.48% to $123.4 million in 2024.
• The last three Shares Outstanding (Diluted Average) figures came in at $123.4 million (Q1 2024), $113.8 million (Q4 2023), and $106.6 million (Q3 2023), per Business Quant data.

Peer Comparison